News

Filter

Current filters:

None

Popular Filters

110 to 134 of 8766 results

Breakthrough status for Amgen’s blinatumomab in ALL

01-07-2014

USA-based Amgen, the world's largest independent biotech firm, says that the US Food and Drug Administration…

AmgenBiotechnologyblinatumomabOncologyRegulationUSA

CureVac in deal with Sanofi Pasteur for mRNA-based prophylactic vaccine

01-07-2014

German clinical-stage biopharma company CureVac has entered into an exclusive license agreement with…

LicensingPharmaceuticalSanofiSanofi PasteurVaccines

Boston Strategics in-licenses Eisai’s cancer candidate E6201

01-07-2014

US clinical-stage drug R&D company Boston Strategics Corp has entered into an exclusive licensing and…

Boston Strategics CorpE6201EisaiLicensingOncologyPharmaceutical

Will innovations in biomarkers lead to a paradigm shift in drug discovery?

01-07-2014

With the efficacy for most drugs targeting severe therapeutic indications ranging from a meagre 25% to…

BiotechnologyEuropeMarkets & MarketingResearch

ALK appoints new Executive Vice President for Product Supply

ALK appoints new Executive Vice President for Product Supply

01-07-2014

Danish allergy specialist ALK-Abello has appointed Helle Skov as new Executive Vice President (Product…

ALK AbelloAlk-AbelloBoardroomDenmarkPharmaceutical

Transcept and Paratek join forces in reverse takeover

Transcept and Paratek join forces in reverse takeover

01-07-2014

US pharma company Transcept Pharmaceuticals and privately-held biopharmaceutical company Paratek Pharmaceuticals…

Antibiotics and Infectious diseasesMergers & AcquisitionsParatek PharmaceuticalsPharmaceuticalTranscept PharmaUSA

bluebird bio acquires Precision Genome Engineering

01-07-2014

US clinical-stage gene therapies firm bluebird bio says it has acquired Precision Genome Engineering,…

Biotechnologybluebird bioMergers & AcquisitionsPrecision Genome Engineering

BioAlliance and Topotarget progress merger plan

BioAlliance and Topotarget progress merger plan

01-07-2014

France-base BioAlliance Pharma and Denmark’s Topotarget say that the shareholders of both companies…

BioAlliance PharmaBiotechnologyMergers & AcquisitionsOncologyOnxeoTopotarget

Ipsen files sNDA for Somatuline for GEP-NETs

Ipsen files sNDA for Somatuline for GEP-NETs

01-07-2014

French drugmaker Ipsen has submitted a Supplemental New Drug Application to the US Food and Drug Administration…

IpsenOncologyPharmaceuticalRegulationSomatulineUSA

pSivida’s marketing authorizations for Iluvien in 10 countries reaches next stage

pSivida’s marketing authorizations for Iluvien in 10 countries reaches next stage

01-07-2014

Drug delivery specialists pSivida says that the regulatory process for marketing authorizations of Iluvien…

EuropeIluvienOphthalmicsPharmaceuticalpSividaRegulation

Biotech clusters with patent strategies are more attractive to big pharma

Biotech clusters with patent strategies are more attractive to big pharma

01-07-2014

Life sciences and biotech research clusters across the UK are benefiting from an improved funding climate…

BiotechnologyFinancialPatentsUK

EMA accepts Merck’s pembrolizumab MAA for review

EMA accepts Merck’s pembrolizumab MAA for review

01-07-2014

US pharma giant Merck & Co says that the European Medicines Agency has accepted for review a Marketing…

EuropeMerck & CoOncologypembrolizumabPharmaceuticalRegulation

Indian generics sector hires India First Group to re-establish its reputation

Indian generics sector hires India First Group to re-establish its reputation

01-07-2014

USA-based generic drugmakers want high quality, low cost generic pharmaceuticals made in India and the…

GenericsHealthcareIndiaPricingUSA

GSK and Theravance submit US sNDA for Breo Ellipta in asthma

GSK and Theravance submit US sNDA for Breo Ellipta in asthma

30-06-2014

US pharma giant GlaxoSmithKline and US partner Theravance have submitted a supplemental New Drug Application…

Breo ElliptaGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravanceUSA

Erbitux equal to Avastin in colorectal cancer survival, FIRE-3 study shows

Erbitux equal to Avastin in colorectal cancer survival, FIRE-3 study shows

30-06-2014

Merck Serono, the biotech subsidiary of Germany’s Merck KGaA, has released positive new clinical trial…

AvastinBiotechnologyErbituxMerck KGaAMerck SeronoOncologyResearchRoche

GSK comments on media coverage of China problems

GSK comments on media coverage of China problems

30-06-2014

UK pharma giant GlaxoSmithKline, already the subject of allegations and investigations of wrongful marketing…

ChinaGlaxoSmithKlineManagementMarkets & MarketingPharmaceutical

Helsinn out-licenses potential NSCLC drug in Turkey

Helsinn out-licenses potential NSCLC drug in Turkey

30-06-2014

Privately-held Swiss pharma group Helsinn said today that rights to anamorelin, its innovative ghrelin…

GEN IlacHelsinnLicensingOncologyPharmaceuticalTurkey

Positive data on Merck & Co’s nausea drug Emend Ph III trial in children

Positive data on Merck & Co’s nausea drug Emend Ph III trial in children

30-06-2014

Positive results have been announced by US pharma giant Merck & Co from a global, investigational Phase…

EmendMerck & CoOncologyPharmaceuticalRegulationResearch

ABPI welcomes first payments to UK’s Pharmaceutical Price Regulation Scheme

ABPI welcomes first payments to UK’s Pharmaceutical Price Regulation Scheme

30-06-2014

The Association of the British Pharmaceutical Industry (ABPI) and the UK’s Department of Health have…

HealthcarePharmaceuticalUK

110 to 134 of 8766 results

Back to top